Literature DB >> 11321234

Fas-FasL in Hashimoto's thyroiditis.

G Stassi1, A Zeuner, D Di Liberto, M Todaro, L Ricci-Vitiani, R De Maria.   

Abstract

Hashimoto's thyroiditis is a common chronic autoimmune disease characterized by the loss of thyroid follicular cells (thyrocytes) that are gradually replaced by lymphocytic infiltration and diffuse fibrosis. These morphological findings suggested that autoreactive T-cell clones were responsible for thyrocyte destruction and hypothyroidism through effector-target cytotoxic recognition. Later, autonomous interaction between thyrocyte Fas and FasL has been proposed as a major mechanism of thyrocyte depletion in Hashimoto's thyroiditis. Here, we analyze the possible role of Fas and FasL in the pathogenesis of Hashimoto's thyroiditis. We suggest that the Fas-FasL system dictates the outcome of the autoimmune response by acting on both immune and target cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11321234     DOI: 10.1023/a:1006732713634

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  31 in total

Review 1.  Fas ligand, death gene.

Authors:  M J Pinkoski; D R Green
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

Review 2.  Chronic autoimmune thyroiditis.

Authors:  C M Dayan; G H Daniels
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

3.  Apoptosis in thyroid diseases: a histochemical study.

Authors:  C Tanimoto; S Hirakawa; H Kawasaki; N Hayakawa; Z Ota
Journal:  Endocr J       Date:  1995-04       Impact factor: 2.349

4.  Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.

Authors:  U Bogner; H Schleusener; J R Wall
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

5.  Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis.

Authors:  R De Maria; L Lenti; F Malisan; F d'Agostino; B Tomassini; A Zeuner; M R Rippo; R Testi
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

Review 6.  Autoimmune thyroid disease: further developments in our understanding.

Authors:  A P Weetman; A M McGregor
Journal:  Endocr Rev       Date:  1994-12       Impact factor: 19.871

Review 7.  Infection, thyroid disease, and autoimmunity.

Authors:  Y Tomer; T F Davies
Journal:  Endocr Rev       Date:  1993-02       Impact factor: 19.871

8.  Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis.

Authors:  N Mitsiades; V Poulaki; V Kotoula; G Mastorakos; S Tseleni-Balafouta; D A Koutras; M Tsokos
Journal:  J Clin Endocrinol Metab       Date:  1998-06       Impact factor: 5.958

9.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells.

Authors:  F Leithäuser; J Dhein; G Mechtersheimer; K Koretz; S Brüderlein; C Henne; A Schmidt; K M Debatin; P H Krammer; P Möller
Journal:  Lab Invest       Date:  1993-10       Impact factor: 5.662

10.  Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases.

Authors:  B Czarnocka; J Ruf; M Ferrand; P Carayon; S Lissitzky
Journal:  FEBS Lett       Date:  1985-10-07       Impact factor: 4.124

View more
  6 in total

1.  Influence of levothyroxine treatment on serum levels of soluble Fas (CD95) and Fas Ligand (CD95L) in chronic autoimmune hypothyroidism.

Authors:  Iraj Nabipour; Mohammadreza Kalantarhormozi; Majid Assadi; Seyed Mojtaba Jafari; Mohammad Gharibi; Esmaeil Ahmadi; Zahra Sanjdideh
Journal:  Endocrine       Date:  2010-11-02       Impact factor: 3.633

2.  Interferon-γ inhibits integrin-mediated extracellular signal-regulated kinase activation stimulated by fibronectin binding in thyroid cells.

Authors:  E Russo; M Salzano; L Postiglione; A Guerra; V Marotta; M Vitale
Journal:  J Endocrinol Invest       Date:  2012-10-01       Impact factor: 4.256

3.  Nonlymphoid Fas ligand in peptide-induced peripheral lymphocyte deletion.

Authors:  Michael J Pinkoski; Nathalie M Droin; Tesu Lin; Laurent Genestier; Thomas A Ferguson; Douglas R Green
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-26       Impact factor: 11.205

Review 4.  Role of apoptosis in autoimmunity.

Authors:  Matilde Todaro; Ann Zeuner; Giorgio Stassi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

5.  Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases.

Authors:  Artur Bossowski; Jerzy Harasymczuk; Anna Moniuszko; Anna Bossowska; Maciej Hilczer; Karol Ratomski
Journal:  Thyroid Res       Date:  2011-09-23

Review 6.  Immune disorders in Hashimoto's thyroiditis: what do we know so far?

Authors:  Aleksandra Pyzik; Ewelina Grywalska; Beata Matyjaszek-Matuszek; Jacek Roliński
Journal:  J Immunol Res       Date:  2015-04-27       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.